Method and compositions for treating obesity, depression,...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

167/274

A61K 31/55 (2006.01) A61K 31/435 (2006.01) A61K 31/44 (2006.01)

Patent

CA 1298201

ABSTRACT OF THE DISCLOSURE Compositions and methods are disclosed for the treatment of obesity, depression, drug abuse, and narcolepsy. The compositions comprise a norepinephrine precursor such as L-tyrosine or L phenylalanine in combination with a norepinephrine re-uptake inhibitor such as desipramine. In another embodiment of the invention, the compositions further comprise enzymatic cofactors for the biosynthesis of norepinephrine. A2.1.TXT 102786

553545

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Method and compositions for treating obesity, depression,... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method and compositions for treating obesity, depression,..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method and compositions for treating obesity, depression,... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1209843

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.